Table 4.
Cancer research investment awards and funding by funding agency (excluding CRUK)
| Funder | All funders where investment data were available |
|||||
|---|---|---|---|---|---|---|
| Number of awards | Percentage of total | Sum investment (£) | Percentage of total | Mean award, £ (SD) | Median award, £ (IQR) | |
| MRC | 768 | 17.9% | £837 649 875 | 35.1% | 1 090 690 (1 770 533) | 504 606 (305 375–1 153 374) |
| Charity (excluding Wellcome and CRUK) | 1699 | 39.5% | £415 189 093 | 17.4% | 244 372 (391 813) | 151 912 (81 000–223 244) |
| Department of Health | 586 | 13.6% | £413 421 823 | 17.3% | 705 498 (2 675 223) | 232 173 (102 391–471 236) |
| BBSRC | 511 | 11.9% | £223 651 002 | 9.4% | 437 673 (388 793) | 373 356 (267 848–501 592) |
| EPSRC | 356 | 8.3% | £201 861 623 | 8.5% | 567 027 (972 696) | 306 906 (144 056–604 016) |
| Wellcome | 193 | 4.5% | £140 425 805 | 5.9% | 727 594 (1 679 370) | 226 761 (164 547–427 455) |
| European Commission (ERC) | 50 | 1.2% | £78 757 447 | 3.3% | 1 575 149 (731 858) | 1 409 678 (1 252 574–1 830 017) |
| Other | 136 | 3.2% | £77 195 650 | 3.2% | 567 615 (1 901 202) | 129 944 (69 309–263 613) |
| Total | 4299 | £2 388 152 318 | 555 513 (1 429 510) | 231 559 (114 619–487 063) | ||
All investment reported in 2013 UK pounds.
BBSRC, Biotechnology and Biological Sciences Research Council; CRUK, Cancer Research UK; EPSRC, Engineering and Physical Science Research Council; ERC, European Research Council; MRC, Medical Research Council.
ERC European Research Council